GFAP and major depressive disorder: Given that astrocytic atrophy and decreased expression of the astrocyte biomarker GFAP have been documented in both animal depression models and autopsy specimens of depressed patients [25], we propose that the impaired APOE4 genotype-dependent glucose metabolism may induce depression susceptibility during stress or aging.